Wendy Stevens to Biosimilar Pharmaceuticals
This is a "connection" page, showing publications Wendy Stevens has written about Biosimilar Pharmaceuticals.
Connection Strength
0,192
-
Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study. Blood Adv. 2021 08 10; 5(15):2958-2964.
Score: 0,192
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.